Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
Research use only
Kovalabs supplies research-grade peptides to qualified researchers for laboratory use only. They are not medicines, are not for human or animal consumption, and are supplied with no dosing or medical guidance.
You must be 18 or over and a qualified person purchasing solely for scientific research.
Selecting ‘I agree’ confirms the above and your acceptance of our Research Disclaimer and Terms of Sale.
Research use only
· 7 min read
Research use only (RUO) is one of three places a chemical can sit in the regulatory landscape, and it is the one most often misread. A licensed medicine and an in-vitro diagnostic each carry a formal grant and a defined set of permitted claims. An RUO reagent carries neither. It is a supply-and-labelling designation that places a material in its own box, and it earns that placement only as long as nobody describes the contents as something to put in a body. This page sets out what the label actually designates, how it sits apart from a licensed medicine and from a diagnostic device, and what documentation a genuine research-use supply chain carries. Everything below describes regulatory and scientific context, not any human or animal use or outcome.
Research use only (RUO) is a supply and labelling designation: a material provided for laboratory research, not validated or approved for diagnostic or therapeutic use in humans or animals. That is the whole of it, and the second clause is doing the heavy lifting. The phrase is not a permission slip and not a disclaimer bolted onto the bottom of a page - it is a statement about what the material has and has not been through. An RUO reagent has been made and, in a credible operation, characterised for identity and purity. It has not been put through the validation that a medicine or a diagnostic requires before it can be presented for use on a person.
The designation says nothing flattering about potency and promises nothing about effect. It is closer to a chain-of-custody statement than a marketing one: this is a defined chemical, supplied to a laboratory, for study. The honest reading of the label is the literal one. It is not code for "use it, we just cannot say so" - read that way, the label stops protecting anything, including the buyer. The whole point of an RUO designation is that the question of what the substance does to a living organism is left open and unasserted, which is exactly the posture a research reagent is meant to hold.
A licensed medicine is a product that holds a marketing authorisation - a formal grant, in the UK regulated by the MHRA under the Human Medicines Regulations 2012 and the Medicines Act 1968, that permits it to be placed on the market and presented for a stated medical purpose in humans. That authorisation is the product of a dossier: defined quality, demonstrated characteristics, and an assessment the regulator has actually reviewed and signed off. An RUO reagent has none of that. It carries no marketing authorisation, has not been evaluated by the MHRA for safety or efficacy, and is not presented for any medical purpose.
The dividing line is not really the substance - it is the presentation. Under MHRA Guidance Note 8, as our note on the UK research-peptide legal position sets out, a material is regulated as a medicine when it is placed on the market with a medicinal claim: a statement, however implicit, that it will produce a physiological effect in a person. The same molecule can be a research reagent on one page and an unlicensed medicine on another, and the only thing that moved was the copy. This is why an RUO label cannot be a loophole. It does not buy the freedom to then describe a benefit, a dose, or an administration route. Add any of those and the designation collapses, regardless of what the vial says.
An in-vitro diagnostic is a different category again, and it is the one most often confused with RUO because both live in the laboratory. An IVD is a device or reagent intended to examine specimens to provide diagnostic information - and as a regulated medical device it must be conformity-assessed and carry a UKCA or CE mark under the Medical Devices Regulations 2002. An IVD has been validated for a defined diagnostic claim. An RUO reagent, by contrast, is explicitly not validated for any diagnostic use; it is supplied for research and carries no diagnostic performance claim at all.
The practical distinction is what the supplier is allowed to promise. An IVD manufacturer can state, within the bounds of its conformity assessment, that the device measures a particular analyte to a particular standard - because it has been assessed against that claim. An RUO supplier can promise that the vial contains what the certificate of analysis says it contains, to the stated purity. It cannot promise the material yields any diagnostic information about a sample, and it does not pretend to. Three categories, three regulators' worth of expectation, three completely different sets of permitted claims - the table below lays them side by side.
| Category | What it is | Who regulates it (UK) | What claims are permitted |
|---|---|---|---|
| Research use only (RUO) reagent | A material supplied for laboratory research, not validated for diagnostic or therapeutic use in humans or animals | Not authorised or evaluated as a medicine or device; supplied outside those frameworks while no human-use claim is made | Identity, purity and chemistry, verifiable against a certificate of analysis. No diagnostic, therapeutic, benefit, dose or human-use claim |
| Licensed medicine | A product holding a marketing authorisation, presented for a stated medical purpose in humans | MHRA, under the Human Medicines Regulations 2012 and the Medicines Act 1968 | The medical claims set out in the authorised product information, within the terms of the marketing authorisation |
| In-vitro diagnostic (IVD) device | A device or reagent intended to examine specimens to provide diagnostic information | MHRA, under the Medical Devices Regulations 2002 (UKCA / CE marking) | The diagnostic performance claims covered by its conformity assessment |
Guidance Note 8 is where the abstract becomes operational. Its logic is presentation-led: the MHRA looks at how a product is marketed, not only at what it physically is, to decide whether it has been placed on the market as a medicine. The practical consequence for the label is narrow, and worth stating once. The RUO designation records that no human-use claim is being made; it cannot create that fact retroactively if a claim has been made elsewhere. A benefit claim, a dosing instruction, or framing that implies administration can reclassify the same material as an unlicensed medicine, and the phrase "research use only" printed underneath changes nothing. The label is a consequence of compliant behaviour, not a substitute for it - which is why a credible operation keeps the same neutral, mechanism-led description on every page, with no outcome claim slipping in even in passing.
A designation is only as good as the paperwork standing behind it, and research-use documentation is where "research use only" stops being a slogan and starts being checkable. The central document is the certificate of analysis: a per-batch record stating the identity and purity of the material, ideally produced by a laboratory with no commercial stake in the result. It is the document that closes the gap between a vial that says one thing and a vial that is one thing. Purity and identity should be verifiable rather than assumed, and a certificate of analysis is the instrument that lets a researcher verify rather than trust. For a field-by-field walkthrough of what those numbers mean, see how to read a peptide CoA.
Around the certificate sit the supporting records that make a batch traceable: a batch or lot number tying the certificate to the physical material, the analytical methods used to establish identity and purity, and storage and handling information. None of this validates the material for use on a living organism - that is precisely the point, and the reason the documentation reads the way it does. It establishes what is in the vial as a matter of chemistry, and stops there. The full research disclaimer sets out the terms on which all of this is supplied.
No. RUO is a genuine supply designation, not a workaround. It holds only while no human-use, benefit, dose or administration claim is made about the material. Treating the label as permission to then describe a use defeats the designation: under MHRA Guidance Note 8 the claim, not the label, decides the regulatory category, and a claim reclassifies the material regardless of what the vial says.
No. A licensed medicine holds a marketing authorisation granted by the MHRA under the Human Medicines Regulations 2012 and the Medicines Act 1968 and has been evaluated for a stated medical purpose. An RUO reagent holds no marketing authorisation, has not been evaluated by the MHRA, and is supplied for laboratory research only.
An IVD is a regulated medical device, conformity-assessed and UKCA or CE marked under the Medical Devices Regulations 2002, and validated for a defined diagnostic claim. An RUO reagent is explicitly not validated for diagnostic use and carries no diagnostic performance claim. Both live in the laboratory, but only the IVD is presented for diagnostic information.
At minimum a per-batch certificate of analysis stating identity and purity, with a batch or lot number tying the certificate to the physical material and the analytical methods used to establish those values. Third-party testing is the stronger position because the testing laboratory has no commercial stake in the answer. Purity and identity should be verifiable rather than assumed.
No. RUO is a statement about category and validation status, not a safety claim. The designation specifically means the material has not been evaluated or approved for use in humans or animals. It records that those questions are open and unasserted, which is the correct posture for a research reagent and the reason this page asserts no effect of any kind.
Every compound supplied by Kovalabs is a research reagent for laboratory use only. It is not a medicine, not a supplement, and not for human or veterinary use. Nothing here is a dose, a route, a schedule or an outcome, and nothing on this page describes use in a person or animal. None of these materials has been evaluated by the MHRA, and none holds a marketing authorisation or a diagnostic conformity assessment. Every batch ships with third-party certificate-of-analysis documentation; the full terms are in the research disclaimer.